U.S. markets closed

Trillium: 1Q Earnings Snapshot

MISSISSAUGA, Ontario (AP) _ Trillium Therapeutics Inc. (TRIL) on Friday reported a loss of $70.1 million in its first quarter.

On a per-share basis, the Mississauga, Ontario-based company said it had a loss of $1.07. Losses, adjusted for non-recurring costs, were 23 cents per share.

Trillium shares have climbed fivefold since the beginning of the year. In the final minutes of trading on Friday, shares hit $5.83, rising ninefold in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TRIL at https://www.zacks.com/ap/TRIL